5-Methyl-1-benzofuran-3-carboxylic acid, 95%, 500mg

3-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97%, 1g

4-nitrobenzyl alcohol, min. 99%, for synthesis, 250 g, glass packaging

2-((5-Bromopyridin-2-yl)oxy)ethanamine dihydrochloride, 1g

2-Methoxy-3,3-dimethylbutanoic acid, 98%, 1g

2-Hydroxy-6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzaldehyde, 96%, 250mg

Praseodymium oxide powder 96% 250 g

(2-Bromo-5-fluoropyridin-4-yl)methanol, 97%, 250mg

1,3-Dichloro-2-(2,2,2-trifluoroethyl)benzene, 95.0%, 5g

[1-(2-methoxyethyl)pyrrolidin-3-yl]methanol, 95.0%, 5g

1-((2,4,6-Triisopropylphenyl)sulfonyl)-1H-imidazole, 98%, 10g

2-Furfuryl thiothiazole, 95.0%, 5g

Methyl 4-phenyl-1H-pyrrole-3-carboxylate, 95.0%, 1g